"Getting tested for STIs on a regular basis is an important action that all New Yorkers can take to optimize their health," health officer Wendy Wilcox said.
The coveted status is for GSK’s NgG vaccine candidate, currently in a phase 2 trial in adults aged 18 to 50 considered to be at risk from infection with Neisseria gonorrhoeae, the bacteria that ...
Neisseria gonorrhoeae, responsible for the sexually transmitted infection gonorrhea, is becoming increasingly difficult to treat as the pathogen has developed resistance to multiple antibiotics.
The WHO estimates that 92 million and 62 million new cases of genital Chlamydia trachomatis and Neisseria gonorrhoeae infection, respectively, occur every year, mostly in areas with limited or no ...
It is caused by bacteria called Neisseria gonorrhoeae or gonococcus, which is found in the semen or vaginal fluid of infected people. It can also be passed from mother to baby during birth ...
There are now multidrug resistant strains of the Neisseria gonorrhoeae (Ng) bacterium - which causes gonorrhoea - making many antibiotics ineffective as first-line treatments. This study has wide ...
a novel compound representing a new antibiotic class that targets Neisseria gonorrhoeae. Multidrug-resistant strains of N. gonorrhoeae have emerged globally, limiting treatment options and ...
US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels: Basel Thursday, January 23, 2025, 09:00 Hrs [IST] Roc ...
In what was known as the RESPECT trial, cash payments offered to young men and women between the ages of 18 and 30 were conditional on testing negative for four curable sexually transmitted infections ...
Neisseria gonorrhoeae, human papillomavirus, Mycobacterium tuberculosis, and Cytomegalovirus and find application in research laboratories and clinical diagnostics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback